SCHEMBL31489786

SCHEMBL31489786

CC[C@H](c1ccc(F)cc1)n1cc(-c2cnc(F)c(-c3ccn4nc(N)nc4c3)c2)cn1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 12/20 0.37
PIK3CD O00329 10/20 0.37
RIPK1 Q13546 1/20 0.35
PIK3CA P42336 2/20 0.33
PAK4 O96013 1/20 0.33
JAK1 P23458 1/20 0.33
PIK3CB P42338 1/20 0.33
CSNK1A1 P48729 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
PIP4K2C Q8TBX8 1/20 0.33
CSNK1G1 Q9HCP0 1/20 0.33
JAK2 O60674 1/20 0.33
CYP17A1 P05093 1/20 0.33
MAPK1 P28482 2/20 0.33
ROCK2 O75116 1/20 0.32
AXL P30530 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489367 1.00 PIK3CG (0.37) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489875 0.89 PIK3CG (0.38) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489277 0.89 PIK3CG (0.38) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489650 0.86 RIPK1 (0.37) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489908 0.86 RIPK1 (0.37) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489392 0.85 PIK3CG (0.40) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489725 0.85 PIK3CG (0.40) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489304 0.84 PIK3CG (0.39) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489876 0.84 PIK3CG (0.39) PIK3CGPIK3CDRIPK1PIK3CAPAK4
SCHEMBL31489389 0.81 RIPK1 (0.40) PIK3CGPIK3CDRIPK1PIK3CAPAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed